Recent Press Releases 08.21.2019 U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer 08.21.2019 Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility in Sanford, North Carolina 08.20.2019 The Pfizer Foundation Invests in 20 Organizations Tackling Infectious Diseases and Antimicrobial Resistance 08.02.2019 Pfizer Announces Phase 3 Top-Line Results for Rivipansel in Patients with Sickle Cell Disease Experiencing a Vaso-Occlusive Crisis 08.01.2019 Pfizer Announces Closing of Joint Venture With GlaxoSmithKline to Create a Premier Global Consumer Healthcare Company 07.30.2019 Pfizer Completes Acquisition of Array Biopharma 07.29.2019 Pfizer Inc. Reschedules Second-Quarter 2019 Earnings Conference Call to July 29, 2019 at 10:30 a.m. EDT 07.29.2019 PFIZER REPORTS SECOND-QUARTER 2019 RESULTS 07.29.2019 Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World’s Need for Medicine 07.23.2019 FDA Approves Pfizer’s Biosimilar, RUXIENCE™ (rituximab-pvvr), for Certain Cancers and Autoimmune Conditions 1 of 154 next › Media Contacts Get to Know Us Company Fact Sheet Featured Stories Press Kits @Pfizer @Pfizer_News by pfizer Tweets by pfizer_news
